by Jordana Choucair | Feb 13, 2023 | Payers
An analysis conducted by the Health Care Cost Institute found that employer-sponsored health plans pay significantly more than Medicare for costly physician-administered drugs. Researchers found that between 2016 and 2020 price markups increased for five of the top 10...
by Jordana Choucair | Feb 13, 2023 | Payers
CMS notified providers and health plans involved in dispute resolution under the Surprise Billing Act to put their payment determinations on hold. Last week, a federal judge ruled in favor of the Texas Medical Association regarding a challenge against the Biden...
by Jordana Choucair | Feb 10, 2023 | Life Sciences
The Biden administration released proposed guidance that outlines the first of a pair of major drug price reforms contained in the Inflation Reduction Act. The initial guidance documents for both physician-administered and pharmacy drugs offer details about the...
by Jordana Choucair | Feb 10, 2023 | Life Sciences
The Senate Judiciary Committee approved via voice vote five bipartisan drug pricing bills that could go before the full Senate soon. One of the bills would limit anticompetitive “pay-for-delay” deals that prevent or delay the introduction of affordable follow-on...
by Jordana Choucair | Feb 10, 2023 | Public Health/Prevention
The Biden administration notified governors that the COVID-19 public health emergency (PHE) will expire on May 11. During a call, U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra said the federal government expects up to 15 million people...
Recent Comments